Kéri G - Search Results

1

Characterization of lipophilicity and antiproliferative activity of E-2-arylmethylene-1-tetralones and their heteroanalogues.

Hallgas B, Dobos Z, Osz E, Hollósy F, Schwab RE, Szabó EZ, Eros D, Idei M, Kéri G, Lóránd T. Hallgas B, et al. Among authors: keri g. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 May 25;819(2):283-91. doi: 10.1016/j.jchromb.2005.02.014. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 15833292

2

Determination of the basicity of Mannich ketones by capillary electrophoresis.

Dobos Z, Lóránd T, Hollósy F, Hallgas B, Eros D, Mészáros G, Kéri G, Idei M. Dobos Z, et al. Among authors: keri g. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jan 5;799(1):179-83. doi: 10.1016/j.jchromb.2003.10.038. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 14659451

3

Comparison of measured and calculated lipophilicity of substituted aurones and related compounds.

Hallgas B, Patonay T, Kiss-Szikszai A, Dobos Z, Hollósy F, Eros D, Orfi L, Kéri G, Idei M. Hallgas B, et al. Among authors: keri g. J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Mar 5;801(2):229-35. doi: 10.1016/j.jchromb.2003.11.021. J Chromatogr B Analyt Technol Biomed Life Sci. 2004. PMID: 14751791

4

Reliability of logP predictions based on calculated molecular descriptors: a critical review.

Eros D, Kövesdi I, Orfi L, Takács-Novák K, Acsády G, Kéri G. Eros D, et al. Among authors: keri g. Curr Med Chem. 2002 Oct;9(20):1819-29. doi: 10.2174/0929867023369042. Curr Med Chem. 2002. PMID: 12369880 Review.

5

Antitumor activity of the somatostatin structural derivative (TT-232), against mouse and human melanoma tumor models.

Tejeda M, Gaál D, Hullán L, Schwab R, Szokoloczi O, Kéri G. Tejeda M, et al. Among authors: keri g. Anticancer Res. 2007 Nov-Dec;27(6B):4015-9. Anticancer Res. 2007. PMID: 18225564 Free article.

6

Continuous administration of the somatostatin structural derivative /TT-232/ by subcutaneously implanted osmotic pump improves the efficacy and potency of antitumor therapy in different mouse and human tumor models.

Tejeda M, Gaal D, Hullán L, Csuka O, Schwab R, Szokoloczi O, Kéri GY. Tejeda M, et al. Among authors: keri gy. Anticancer Res. 2008 Sep-Oct;28(5A):2769-74. Anticancer Res. 2008. PMID: 19035308 Free article.

7

Structure -activity relationships of PDE5 inhibitors.

Eros D, Szántai-Kis C, Kiss R, Kéri G, Hegymegi-Barakonyi B, Kövesdi I, Orfi L. Eros D, et al. Among authors: keri g. Curr Med Chem. 2008;15(16):1570-85. doi: 10.2174/092986708784911524. Curr Med Chem. 2008. PMID: 18673225 Review.

8

A comparison of the tumor growth inhibitory effect of intermittent and continuous administration of the somatostatin structural derivative TT-232 in various human tumor models.

Tejeda M, Gaál D, Hullán L, Csuka O, Schwab R, Szokoloczi O, Kéri G. Tejeda M, et al. Among authors: keri g. Anticancer Res. 2006 Jul-Aug;26(4B):3011-5. Anticancer Res. 2006. PMID: 16886628 Free article.

9

TT-232: a somatostatin structural derivative as a potent antitumor drug candidate.

Szende B, Kéri G. Szende B, et al. Among authors: keri g. Anticancer Drugs. 2003 Sep;14(8):585-8. doi: 10.1097/00001813-200309000-00002. Anticancer Drugs. 2003. PMID: 14501379 Review.

10

The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts.

Tejeda M, Gaal D, Barna K, Csuka O, Kéri G. Tejeda M, et al. Among authors: keri g. Anticancer Res. 2003 Sep-Oct;23(5A):4061-6. Anticancer Res. 2003. PMID: 14666719

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters